<a href="https://medicalip.net:8085/download_?filePath=bbs/view_img.php?img=http%3A%2F%2Fmenu.mtn.co.kr%2Fupload%2Farticle%2F2019%2F11%2F13%2F2019111314455256871_00_559.png" target="_blank" class="view_image" style="box-sizing: border-box; color: rgb(0, 0, 0); font-family: &quot;Noto Sans KR&quot;, sans-serif; font-size: 17.5px;"><img itemprop="image" content="http://menu.mtn.co.kr/upload/article/2019/11/13/2019111314455256871_00_559.png" src="http://menu.mtn.co.kr/upload/article/2019/11/13/2019111314455256871_00_559.png" alt="" class="img-tag img-tag article-photo-news center" width="647" title="" style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: middle; font-size: 1em; max-width: 100%; height: auto; width: 650px;"></a><br style="box-sizing: border-box; color: rgb(51, 51, 51); font-family: &quot;Malgun Gothic&quot;, 맑은고딕, &quot;Nanum Gothic&quot;, 나눔고딕, Dotum, 돋움, Helvetica, AppleGothic, sans-serif; font-size: 18px; letter-spacing: -0.4px;">MEDIP, a medical image analysis solution developed by
Medical IP, has been proven to be effective and safe from the US Food and Drug
Administration (FDA). (Hereinafter omitted)<o:p></o:p> [Source]&nbsp;MTN <a href="http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019111314455256871" style="box-sizing: border-box; color: rgb(0, 0, 0); font-family: &quot;Noto Sans KR&quot;, sans-serif; font-size: 17.5px;">http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019111314455256871</a>&nbsp;&nbsp;

MEDICALIP attracts attention with 'AI medical technology' approved by FDA 

Leading Korean AI medical imaging companies showcase key products at KCR 2023

MEDICAL IP won the ‘Innovation Grand Prize’ at the <KHF Innovation Award>

Changing the ‘Future of anatomy’ through MEDICAL IP's AI and digital twin technology

MEDICAL IP, Selected as Gartner's Sample Vendor for 6 Consecutive Years

MEDICAL IP conducted an advanced medical education curriculum at Seoul National University.

MEDICAL IP's DeepCatch offers new global standard in body composition

MEDICAL IP participates in ‘ESGAR 2023’ and introduces CT body composition analysis technology

MEDICAL IP Is Creating Medical Digital Twins in Virtual Spaces, Powered by NVIDIA Omniverse

MEDICAL IP joins NVIDIA’s Medical Imaging and Healthcare AI Council

MEDICAL IP Signs Letter Of Support With AWS

MEDICAL IP’s, X-ray based lung volumetry analysis S/W ‘TiSepX Lung Volumetry’ gains MFDS approval

MEDICAL IP to participate ECR 2023 Presenting AI · Digital Twin-based Medical Solutions

MEDICAL IP Coming to CES 2023… Introducing Its Metaverse-based Medical IT Tech

[RSNA 2022] 'MEDICAL IP’s AI tech covers diagnosis, prevention, and pre-surgery’ 

MEDICAL IP, participating in ‘RSNA 2022’… Accelerating entry into the global medical market

MEDICAL IP To Participate ‘Annual Meeting of the Korean Association of Anatomists 

MEDICAL IP to Participate in the 'AOCR & KCR 2022'

MEDICAL IP, ‘NVIDIA Inception’ Premier Partnership Agreement

MEDICAL IP Selected as Sample Vendor by Gartner for 5 Consecutive Years

MEDICAL IP participates in ‘ECR 2022’, European Society of Radiology

MEDICAL IP hires employees from various positions to advance the ‘medical metaverse’

MEDICAL IP-Korean Association of Anatomists signed an MOU for the development of metaverse medicine based on ‘digital twin’

MEDICAL IP-L&K Biomed, MOU signed

MEDICAL IP-Hallym University Medical Center to build a medical metaverse ecosystem

MEDICAL IP-United Imaging Healthcare, Signing an MOU to Mount AI Body Composition Analysis Solution into Medical Devices

MEDICAL IP received the Minister of Health and Welfare Award.

MEDICAL IP, Participated in KIMES 2022 Medical Korea 2022

MEDICAL IP - International St. Mary's Hospital - Incheon Catholic University signed MOU

MEDICAL IP acquires Ministry of Food and Drug Safety certification, for the first time in Korea, for AR technology realizing ‘Medical Metaverse’

MEDICAL IP-Incheon Catholic University signed an MOU for nurturing future human resources for the medical metaverse and industrial development

MEDICAL IP and Dankook University Hospital signed an agreement to introduce next-generation medical technology

MEDICAL IP, leading the 'Medical Metaverse' technology... Commendation from the Minister of Commerce, Industry and Energy industry

MEDICAL IP unveils 'Medical Metaverse' for the first time at ‘RSNA 2021’

[RSNA 2021] MEDICAL IP showcases AI segmentation technology

MEDICAL IP, selected as ‘100 Excellent National R&D Performances 2021’ by the Ministry of Science and ICT

MEDICAL IP confirms quantification of COVID-19 and predictability of risk through international academic journal

"We have the most advanced body composition division technology"

MEDICAL IP launches 30 types of AI modules that automatically divide anatomical structures

"AI technology that can identify diseases only with X-rays and CTs to be distributed around the world"

MEDICAL IP CEO Sang-Joon Park participates in 'Children's Traffic Safety Challenge'

MEDICAL IP, Multi-disease prediction and prevention AI solution unveiled at KCR 2021

MEDICAL IP, commercial realization of ‘Disease prediction AI’…

MEDICAL IP conquers 'brain disease' with AI imaging technology and 3D printing

MEDICAL IP, first in Korea to apply 'Metaverse' to practical education at Seoul National University College of Medicine

20 billion investment completed... where is the new office for MEDICALIP?

MEDICALIP "Prevention of disease and prognosis management with AI"

From examination analysis to surgery planning... 'AI' is very active in the medical field.

MEDICAL IP to attract investment in Series C... Partnership with Dong-A Socio Holdings

MEDICAL IP, AI-based preventive medicine agreement with Seoul National University Hospital Gangnam Center

MEDICAL IP and OlympusKorea jointly develop 3D printing simulator

MEDICAL IP, confirms the usefulness of patient-specific brain tumor 3D printing models

MEDICALIP, first introduced ‘Disease Prevention and Monitoring AI’ technology at KIMES 2021

MEDICALIP-Bertis, MOU for development of bio-dual complex AI platform

AI for “monitoring” patients fills the gap in COVID-19 treatment.

MEDICAL IP, Supplying ‘ANATDEL’ to SNUH Thoracic and Cardiovascular Surgery

IT to find a solution to ‘prediction and diagnosis’ of elderly diseases

[AI] "COVID-19 infiltrating the lung, 'AI TiSepX' finds it all"

MEDICAL IP, AI body composition analysis solution 'DeepCatch' medical device class 2 certification

MEDICAL IP, full-pledged IPO promotion

MEDICALIP selected as 'National Representative of Innovative Company' and 'Innovation Icon'

Naming| 'DeepCatch' to 'catch' body composition through deep learning

MEDICAL IP, Free release of X-ray-based COVID-19 quantification platform worldwide

MEDICAL IP to participate in RSNA 2020 to introduce 'AI medical solution' based on CT, MRI, and X-ray images

MEDICAL IP, awarded by the Ministry of SMEs and Startup

MEDICAL IP, selected as a full-cycle medical device research and development project

AI technology leads to a paradigm shift in body composition analysis

MEDICAL IP, AI pneumonia analysis SW approved for medical device grade 3 from the MFDS

MEDICAL IP to participate in K-HOSPITAL FAIR and KIMES Busan 

MEDICAL IP "Knowledge saving patients, realization is key"

Sang-Joon Park, CEO of MEDICAL IP "K-Defense Rapid Response is thanks to the cloud"

MEDICALIP, '14 3D Printing Medical Guides' Approved for Class 1 Medical Device

MEDICAL IP to introduce 'Innovative Medical Technology' based on AI

MEDICALIP and Seoul St. Mary's Hospital signed an MOU for joint development of anatomical models

MEDICAL IP and Medtronic Korea to jointly develop 3D printing anatomical model 

"Vigorously reflecting the Korean version of the New Deal project in next year's budget" 

MEDICAL IP, selected as Gartner Sample Vendor for 3 consecutive years

MEDICAL IP saves more lives with medical big data

Diagnosis of COVID-19 in 1 minute with AI technology… Companies selected as ‘D.N.A. innovative companies’ 

MEDICAL IP, prepared for leading ‘data labeling,’ the core of the Korean version of New Deal 

MEDICAL IP completes 'non-face-to-face' education curriculum at SNU College of Medicine

Ministry of Science and ICT selected MEDICALIP as 'DNA' excellent company in May

MEDICAL IP unveils world's first quantitative COVID-19 SW 

Korea Information Technology Agency (NIA), published 'Korean ICT Services against COVID-19 Pandemic'

K-Bio, physician start-up company gathers in one place

ArirangTV [Money Monster] - ICT for the arrival of the "New Normal"

Seoul National University's 1st startup, X-ray → 3D COVID-19 analysis solution to be released

“1,048 institutions from 41 countries have downloaded… I hope this will help to solve the pandemic promptly.”

"Check your condition with your smartphone before visiting the hospital ..." Check the 3D surgery plan

[3DHEALS] Interview with Dr. Sang Joon Park, CEO of MEDICALIP 

MEDICALIP 'MEDIP COVID19' download in 39 countries

[Let's Startup] MEDICALIP Shows Patients' Black and White CT Photos in '3D Color'

[Interview] "Corona diagnosis in 1 minute with AI technology" 

AI technology diagnoses corona19 in 1 minute… Proven by joint research between Korea·China·Japan 

Arirang TV - Money Monster  "3D printing for medical devices"

MEDICALIP Released COVID-19 Analysis Software 'MEDIP COVID19' as a freeware 

Korea-China medical team collaborates on COVID-19 diagnostic AI technology

MEDICALIP to develop animal medical AI solution with Woorien 

MEDICALIP Delivers 100th 3D Printing Kidney Model to Seoul National University 

MEDICALIP-Sejong Hospital Joins Forces to Improve Cerebrovascular Disease Prediction and Diagnosis 

"Aims for game changers in the conservative medical device market" 

MEDICALIP attracts attention with 'AI medical technology' approved by FDA

LATEST NEWS

Leading Korean AI medical imaging companies showcase key products at KCR 2023

MEDICAL IP won the ‘Innovation Grand Prize’ at the <KHF Innovation Award>

Changing the ‘Future of anatomy’ through MEDICAL IP's AI and digital twin technology

MEDICAL IP, Selected as Gartner's Sample Vendor for 6 Consecutive Years

···

Questions on our public relations?

Ask us now.